Study of a new treatment to preserve insulin-making cells in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a medicine called anti-thymocyte globulin (h-ATG) to see if it can help people with type 1 diabetes keep making some of their own insulin. It may slow the loss of insulin-making cells and help manage blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 40 years old.
- You have been diagnosed with type 1 diabetes within the last 2 years.
- Your body still makes some insulin (shown by a blood test).
- You have at least one type 1 diabetes-related antibody in your blood.
- You are willing to receive required vaccines and avoid other experimental treatments during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug that may help preserve the body's ability to make insulin in people with type 1 diabetes. It aims to slow the progression of the disease and reduce the need for insulin injections.
This study tests a new treatment called GNTI-122 for adults recently diagnosed with type 1 diabetes who still make some insulin. It aims to see if the treatment can help protect the cells that produce insulin.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
This study tests whether a medicine called golimumab can slow down or stop type 1 diabetes from getting worse in people who are in the earliest stage of the disease. Participants are randomly assigned to receive either golimumab or a placebo (a dummy shot) to see if the medicine helps protect the body's insulin-making cells.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.